New cancer drugs could treat lethal resistant prostate cancers

Posted by on May 1, 2016 6:25 pm
Categories: health

Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class of cancer drug designed to overcome drug resistance, a new study suggests. Researchers found that the drugs, called Hsp90 inhibitors, specifically target and inactivate a mechanism commonly used by prostate cancer cells to evade the effects of standard treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *